Impact of an educational flyer and sensitization on performance-enhancement attitudes of bodybuilders in United Arab Emirates.

Bodybuilders doping educational intervention performance enhancement

Journal

F1000Research
ISSN: 2046-1402
Titre abrégé: F1000Res
Pays: England
ID NLM: 101594320

Informations de publication

Date de publication:
2023
Historique:
accepted: 12 04 2024
pubmed: 23 2 2023
medline: 28 3 2024
entrez: 27 3 2024
Statut: epublish

Résumé

A high proportion of bodybuilders use supplements to improve performance, with some turning to prohibited substances and methods. The attitudes of bodybuilders towards performance enhancement may be gauged through surveys such as the Performance Enhancement Attitude Scales (PEAS). Educational interventions are recommended as part of anti-doping measures. The objective of this project was to assess the impact of a pharmacy-led intervention using an antidoping educational flyer and the performance enhancement attitude scale to measure the attitude of bodybuilders in the United Arab Emirates (UAE). The PEAS eight-item short form questionnaire was administered to male bodybuilders in the UAE. The PEAS was conducted before and after administration of an educational flyer concerning the problems associated with supplement use among bodybuilders. The Wilcoxon Signed-Rank and Kruskal Wallis tests were used for data analysis. A total of 218 bodybuilders, who reported taking dietary supplements, filled out the survey both pre and post viewing the antidoping educational flyer. A difference was observed between the full-time professional bodybuilders, students, and part-time bodybuilders with other primary occupations (p-value <0.05). In addition, PEAS score decreased among the study population for all eight PEAS items (p-value <0.05). The pharmacy-led intervention using an antidoping educational flyer and sensitization by PEAS achieved more favorable scores, suggesting a significant shift of opinion toward avoiding use of performance enhancing substances among the bodybuilder study population. More research is required on sustaining the attitude and demonstrating the impact on doping behavior.

Sections du résumé

Background UNASSIGNED
A high proportion of bodybuilders use supplements to improve performance, with some turning to prohibited substances and methods. The attitudes of bodybuilders towards performance enhancement may be gauged through surveys such as the Performance Enhancement Attitude Scales (PEAS). Educational interventions are recommended as part of anti-doping measures. The objective of this project was to assess the impact of a pharmacy-led intervention using an antidoping educational flyer and the performance enhancement attitude scale to measure the attitude of bodybuilders in the United Arab Emirates (UAE).
Methods UNASSIGNED
The PEAS eight-item short form questionnaire was administered to male bodybuilders in the UAE. The PEAS was conducted before and after administration of an educational flyer concerning the problems associated with supplement use among bodybuilders. The Wilcoxon Signed-Rank and Kruskal Wallis tests were used for data analysis.
Results UNASSIGNED
A total of 218 bodybuilders, who reported taking dietary supplements, filled out the survey both pre and post viewing the antidoping educational flyer. A difference was observed between the full-time professional bodybuilders, students, and part-time bodybuilders with other primary occupations (p-value <0.05). In addition, PEAS score decreased among the study population for all eight PEAS items (p-value <0.05).
Conclusions UNASSIGNED
The pharmacy-led intervention using an antidoping educational flyer and sensitization by PEAS achieved more favorable scores, suggesting a significant shift of opinion toward avoiding use of performance enhancing substances among the bodybuilder study population. More research is required on sustaining the attitude and demonstrating the impact on doping behavior.

Identifiants

pubmed: 38533422
doi: 10.12688/f1000research.130700.1
pmc: PMC10964001
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

208

Informations de copyright

Copyright: © 2024 Thomas D et al.

Déclaration de conflit d'intérêts

No competing interests were disclosed.

Références

BMC Sports Sci Med Rehabil. 2021 Jan 4;13(1):1
pubmed: 33397493
Ann Saudi Med. 2017 Jul-Aug;37(4):317-325
pubmed: 28761032
Scand J Med Sci Sports. 2013 Mar;23(2):244-52
pubmed: 22092778
Int J Drug Policy. 2020 Aug;82:102820
pubmed: 32563179
Phys Med Rehabil Res. 2018;3(6):1-8
pubmed: 31172033
BMC Complement Altern Med. 2019 Jan 3;19(1):1
pubmed: 30606178
Front Psychol. 2018 Aug 08;9:1431
pubmed: 30135676
Front Psychol. 2020 Sep 23;11:561013
pubmed: 33071886
Subst Abuse Treat Prev Policy. 2007 Jan 04;2:1
pubmed: 17204156
Glob Health Action. 2013 Feb 05;6:20100
pubmed: 23394856
PLoS One. 2015 Apr 22;10(4):e0118507
pubmed: 25902142
BMJ Open Sport Exerc Med. 2021 Jan 07;7(1):e000957
pubmed: 33489309
Subst Abuse Treat Prev Policy. 2022 Jan 3;17(1):1
pubmed: 34980179
J Health Psychol. 2019 Sep;24(11):1595-1612
pubmed: 29096544
Harm Reduct J. 2019 Jan 5;16(1):1
pubmed: 30611251
Int J Surg Pathol. 2014 Dec;22(8):688-94
pubmed: 25311454
Front Psychol. 2017 May 09;8:749
pubmed: 28536552
J Int Soc Sports Nutr. 2014 Mar 27;11(1):13
pubmed: 24670105
BMJ Open Sport Exerc Med. 2020 Oct 01;6(1):e000800
pubmed: 33088583
Perspect Public Health. 2017 Sep;137(5):275-280
pubmed: 27810999

Auteurs

Dixon Thomas (D)

College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates.

Adhnan Abdul Shabeek (AA)

College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates.

Hala Ahmed (H)

College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates.

Malak Mohammed (M)

College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates.

Marina Kawaguchi-Suzuki (M)

School of Pharmacy, Pacific University, Oregon, USA.

Ashley Anderson (A)

International Sports Pharmacists Network, Colorado, USA.

Aji Gopakumar (A)

Department of Research, Emirates Health Services, Dubai, United Arab Emirates.

Reema Alhosani (R)

National Antidoping Agency, Dubai, United Arab Emirates.

Sherief Khalifa (S)

College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates.

David Mottram (D)

Pharmacy and pharmaceutical science, Liverpool John Moores University, Liverpool, UK.

Classifications MeSH